SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2977Why MNTA? siliconinvestor.comDewDiligence_on_SI-8/25/2015
2976MNTA Momenta initiates equity offering Momenta Pharmaceuticals (NASDAQ: MNTA) The Ox-5/18/2015
2975About time. this should get interesting now.mopgcw-4/16/2015
2974What's your opinion with regards to the influence of TEVA's legal maneuvDewDiligence_on_SI-6/25/2014
2973What's your opinion with regards to the influence of TEVA's legal maneuvsemi_infinite -6/25/2014
2972FDA finally approved Teva’s generic Lovenox: siliconinvestor.com This would’DewDiligence_on_SI-6/24/2014
2971Goldman Sach's call to short TEVA using puts spiked the option volume on TEVsemi_infinite -5/22/2014
2970When they announced the ATM, that was indication of launch to me. The benefits semi_infinite -5/13/2014
2969MNTA plans to “aggressively” build Copaxone inventory after 5/24/14, according tDewDiligence_on_SI-5/13/2014
2968Thanks. I suppose I need not be surprised by the muted mnta movement. The stocsemi_infinite -5/12/2014
2967Two separate questions: 1) Will NVS/MNTA get FDA approval for Gx Copaxone in theDewDiligence_on_SI-5/11/2014
2966It's been a while since I played the Lovenox launch. MNTA seems surprisinglsemi_infinite -5/9/2014
2965<I> With the mEnox revenue stream a trickle compared to the burn, it'smopgcw-4/7/2014
2964Musings on 3xW Copaxone’s commercial uptake from an industry insider: siliconinvDewDiligence_on_SI-4/4/2014
2963>> i tend to think the insurers will be more amenable to pushing the cheaptuck-4/4/2014
2962perhaps. i tend to think the insurers will be more amenable to pushing the cheamopgcw-4/4/2014
2961i am not sure that is a fair assessment -- this was always going to a full boat mopgcw-4/4/2014
2960Dew thinks they'll launch at risk if they get approval but why would sharehoDaveAu-4/2/2014
2959So the bear thesis is that by the time the legal struggles are over, Teva will htuck-4/2/2014
2958we're off to see the wizard...I mean the supreme court... alas delay the inemopgcw-3/31/2014
2957Teva recently held a type C meeting with the FDA regarding differences between btuck-3/9/2014
2956Presumably some know-how will be kept as trade secrets in light of the current ltuck-12/6/2013
2955From prior patent filings, I think Orencia may be the lead FoB in the program (aDewDiligence_on_SI-12/6/2013
2954FloBlu from IHub digs out Momenta patents that specifically mention marketed biotuck-12/6/2013
2953still holding for the long haul here. I think about taking some chips off the tmopgcw-7/29/2013
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News